These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does CRISPR-Cas open new possibilities for patents or present a moral maze? Webber P Nat Biotechnol; 2014 Apr; 32(4):331-3. PubMed ID: 24714479 [No Abstract] [Full Text] [Related]
3. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint. Crespi RS Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007 [TBL] [Abstract][Full Text] [Related]
4. Alienation from the Objectives of the Patent System: How to Remedy the Situation of Biotechnology Patent. Jiang L Sci Eng Ethics; 2019 Jun; 25(3):791-811. PubMed ID: 29532279 [TBL] [Abstract][Full Text] [Related]
5. Patent prosecution strategies for biotechnological inventions. Yeh JJ; Fernandez D Assay Drug Dev Technol; 2004 Dec; 2(6):697-702. PubMed ID: 15674028 [TBL] [Abstract][Full Text] [Related]
6. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies. Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699 [TBL] [Abstract][Full Text] [Related]
7. Ethics and patentability in biotechnology. Witek R Sci Eng Ethics; 2005 Jan; 11(1):105-11. PubMed ID: 15727006 [TBL] [Abstract][Full Text] [Related]
8. Patentability of life and ethics. Lenoir N C R Biol; 2003; 326(10-11):1127-34. PubMed ID: 14744124 [TBL] [Abstract][Full Text] [Related]
9. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany. Schrell A; Bauser H; Brunner H Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818 [TBL] [Abstract][Full Text] [Related]
10. The attack of the clones: patent law and stem cell research. Rimmer M J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321 [TBL] [Abstract][Full Text] [Related]
11. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]
12. Ethical questions to ponder in the European stem cell patent debate. Curley D; Sharples A J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135 [TBL] [Abstract][Full Text] [Related]
13. Towards harmonization: the European biotechnology patent directive. Curley D J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122 [TBL] [Abstract][Full Text] [Related]
14. Brave new industry, that has such patents in it! Reflections on the economic consequences of patenting DNA. Cockburn IM Adv Genet; 2003; 50():385-98; discussion 507-10. PubMed ID: 14714701 [No Abstract] [Full Text] [Related]
15. Innovations and intellectual property: the case of genomic patenting. Jackson BA J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760 [TBL] [Abstract][Full Text] [Related]
16. Bio-patents, law and ethics. Critical analysis of the EU biotechnology directive. Van Overwalle G Rev Derecho Genoma Hum; 2003; (19):187-203. PubMed ID: 15032104 [No Abstract] [Full Text] [Related]
17. Patenting of human embryonic stem cells in Europe. Treichel P Biotechnol J; 2009 Apr; 4(4):462-4. PubMed ID: 19370720 [No Abstract] [Full Text] [Related]
18. Some empirical evidence on how technologically complex issues are decided in patent cases in U.S. District Courts. McKelvie RR Adv Genet; 2003; 50():459-70; discussion 507-10. PubMed ID: 14714706 [No Abstract] [Full Text] [Related]
19. Patenting DNA: who defines and protects the public good? Garcia SA Am J Bioeth; 2002; 2(3):25-6. PubMed ID: 12230850 [No Abstract] [Full Text] [Related]
20. Patents: patenting of stem cell related inventions in Europe. Rutz B; Yeats S Biotechnol J; 2006 Apr; 1(4):384-7. PubMed ID: 16892264 [No Abstract] [Full Text] [Related] [Next] [New Search]